Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 22 | 6 | 1991 | 2017 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
phenotype | 0.100 | None | 1.000 | 14 | 3 | 2001 | 2015 | ||||||||
|
B-Raf proto-oncogene, serine/threonine kinase | 0.319 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 8 | 7 | 1968 | 2013 | ||||||||
|
brain derived neurotrophic factor | 0.345 | 0.923 | 0.66 |
|
phenotype | 0.100 | None | 1.000 | 6 | 1 | 2001 | 2018 | ||||||||
|
notch receptor 1 | 0.369 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 19 | 1 | 1999 | 2019 | ||||||||
|
Fas cell surface death receptor | 0.372 | 0.923 | 0.81 |
|
phenotype | 0.100 | None | 1.000 | 9 | 1 | 1995 | 2016 | ||||||||
|
HRas proto-oncogene, GTPase | 0.378 | 0.885 | 8.0E-02 |
|
phenotype | 0.100 | None | 1.000 | 5 | 1 | 2006 | 2012 | ||||||||
|
BRCA2 DNA repair associated | 0.379 | 0.846 | 2.4E-25 |
|
phenotype | 0.100 | None | 1.000 | 10 | 2 | 1998 | 2011 | ||||||||
|
lamin A/C | 0.384 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
solute carrier family 2 member 1 | 0.388 | 0.808 | 0.99 |
|
phenotype | 0.100 | None | 0 | 1 | |||||||||||
|
ret proto-oncogene | 0.392 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 12 | 1 | 1994 | 2012 | ||||||||
|
gap junction protein alpha 1 | 0.393 | 0.885 | 0.16 |
|
phenotype | 0.100 | None | 1.000 | 12 | 1 | 2003 | 2017 | ||||||||
|
patched 1 | 0.398 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 13 | 2 | 1996 | 2016 | ||||||||
|
lysine methyltransferase 2A | 0.410 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 22 | 7 | 1989 | 2017 | ||||||||
|
synaptotagmin 1 | 0.412 | 0.846 | 0.60 |
|
phenotype | 0.100 | None | 1.000 | 18 | 2 | 1994 | 2016 | ||||||||
|
transforming growth factor beta receptor 2 | 0.413 | 0.846 | 0.13 |
|
phenotype | 0.100 | None | 1.000 | 6 | 1 | 2005 | 2016 | ||||||||
|
methyl-CpG binding protein 2 | 0.414 | 0.846 | 0.89 |
|
phenotype | 0.400 | None | 1.000 | 19 | 10 | 1993 | 2016 | ||||||||
|
elastin | 0.415 | 0.885 | 2.1E-14 |
|
phenotype | 0.100 | None | 1.000 | 9 | 1 | 1994 | 2017 | ||||||||
|
fibrillin 1 | 0.417 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 29 | 2 | 1986 | 2016 | ||||||||
|
Raf-1 proto-oncogene, serine/threonine kinase | 0.418 | 0.885 | 0.85 |
|
phenotype | 0.100 | None | 1.000 | 15 | 1 | 2006 | 2016 | ||||||||
|
CREB binding protein | 0.428 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 18 | 2 | 1963 | 2017 | ||||||||
|
collagen type I alpha 1 chain | 0.430 | 0.808 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 20 | 2 | 1957 | 2017 | ||||||||
|
transforming growth factor beta 2 | 0.433 | 0.885 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 7 | 1 | 2004 | 2015 | ||||||||
|
SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily b, member 1 | 0.434 | 0.846 | 1.00 |
|
phenotype | 0.100 | None | 1.000 | 5 | 2 | 2012 | 2014 | ||||||||
|
SPG7 matrix AAA peptidase subunit, paraplegin | 0.436 | 0.885 | 2.0E-36 |
|
phenotype | 0.100 | None | 0 | 1 |